Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fonatsch

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
American Journal of Hematology|May 20, 1999
Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cellsF Wimazal, W R Sperr, H P Horny, et al.
Bone Marrow Transplantation|May 13, 1998
Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donorsH T Greinix, E Reiter, F Keil, et al.
Leukemia|March 10, 2001
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplantsF Keil, E Prinz, P Kalhs, et al.
Leukemia|April 29, 2005
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemiaD Heintel, D Kienle, M Shehata, et al.
Human Genetics|January 1, 1981
Preferential maternal derivation in inv dup(15): analysis of eight new casesP Maraschio, O Zuffardi, F Bernardi, et al.
Blood|June 11, 1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative GroupT Büchner, W Hiddemann, B Wörmann, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Therapy of chronic myeloid leukemia with interferon-alpha. A decade of experiences]M Freund, P Heussner, F Hild, et al.
Leukemia & Lymphoma|October 1, 1996
Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOGT Haferlach, J M Bennett, H Löffler, et al.
Leukemia|September 30, 2005
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)U Germing, B Hildebrandt, M Pfeilstöcker, et al.
Annals of Hematology|June 2, 2000
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemiaH T Greinix, H Loidolt, W Rabitsch, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|May 20, 1999
Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cellsF Wimazal, W R Sperr, H P Horny, et al.
Bone Marrow Transplantation|May 13, 1998
Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donorsH T Greinix, E Reiter, F Keil, et al.
Leukemia|March 10, 2001
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplantsF Keil, E Prinz, P Kalhs, et al.
Leukemia|April 29, 2005
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemiaD Heintel, D Kienle, M Shehata, et al.
Human Genetics|January 1, 1981
Preferential maternal derivation in inv dup(15): analysis of eight new casesP Maraschio, O Zuffardi, F Bernardi, et al.
Blood|June 11, 1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative GroupT Büchner, W Hiddemann, B Wörmann, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Therapy of chronic myeloid leukemia with interferon-alpha. A decade of experiences]M Freund, P Heussner, F Hild, et al.
Leukemia & Lymphoma|October 1, 1996
Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOGT Haferlach, J M Bennett, H Löffler, et al.
Leukemia|September 30, 2005
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)U Germing, B Hildebrandt, M Pfeilstöcker, et al.
Annals of Hematology|June 2, 2000
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemiaH T Greinix, H Loidolt, W Rabitsch, et al.
Pageof 16